52-Week High Guru Stocks: BIIB, GE, BDX, IR, PFE

By
A A A

According to GuruFocus' list of 52-week highs , these Guru stocks have reached their 52-week highs.

Biogen Idec Inc. ( BIIB ) Reached the 52-Week High of $154.58

The prices of Biogen Idec Inc. ( BIIB ) shares have reached $154.58, which is 1.0% off the 52-week high of $156.06. IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research, development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases. Biogen Idec Inc. has a market cap of $36.04 billion; its shares were traded at around $154.58 with a P/E ratio of 24.3 and P/S ratio of 7.1. Biogen Idec Inc. had an annual average earnings growth of 19.8% over the past five years.

Biogen Idec Inc. announced its second quarter 2012 results. Second quarter revenues increased 18% to $1.4 billion, compared to the second quarter of 2011. Revenues from other products in the second quarter of 2012 were $34 million, compared to $16 million in the second quarter of 2011.

CEO George A. Scangos , Director Robert W. Pangia and Director Stephen A. Sherwin sold shares of BIIB stock.

General Electric Company ( GE ) Reached the 52-Week High of $22.54

The prices of General Electric Company ( GE ) shares have reached $22.54, which is 0.3% off the 52-week high of $22.61. General Electric is one of the largest and most diversified industrial corporations in the world. General Electric Company has a market cap of $228.02 billion; its shares were traded at around $22.54 with a P/E ratio of 15.2 and P/S ratio of 1.6. The dividend yield of General Electric Company stocks is 3.2%. General Electric Company had an annual average earnings growth of 10.3% over the past 10 years.

Director John Joseph Brennan, Director Alan G. Lafley and Director Rochelle B. Lazarus bought shares of GE stock.

Vice Chairman John Krenicki sold shares of GE stock.

Becton, Dickinson and Co. ( BDX ) Reached the 52-Week High of $79.32

The prices of Becton, Dickinson and Co. ( BDX ) shares have reached $79.32, which is 1.5% off the 52-week high of $80.53. Becton, Dickinson and Co. is engaged principally in the manufacture and sale of a broad line of supplies, devices and systems used by health care professionals, medical research institutions and the general public. Becton, Dickinson And Co. has a market cap of $15.54 billion; its shares were traded at around $79.32 with a P/E ratio of 14.3 and P/S ratio of 2. The dividend yield of Becton, Dickinson And Co. stocks is 2.3%. Becton, Dickinson And Co. had an annual average earnings growth of 11.9% over the past 10 years. GuruFocus rated Becton, Dickinson And Co. the business predictability rank of 5-star.

Senior Vice President Human Resources Donna M Boles, Director Alfred Sommer, and Senior Vice President and General Counsel Jeffrey S. Sherman sold shares of BDX stock.

Ingersoll-Rand Plc ( IR ) Reached the 52-Week High of $46.92

The prices of Ingersoll-Rand Plc ( IR ) shares have reached $46.92, which is 0.0% off the 52-week high of $46.92. Ingersoll Rand Company is one of the providers of security and safety, climate control, industrial productivity and infrastructure products. Ingersoll-rand Plc has a market cap of $14.22 billion; its shares were traded at around $46.92 with a P/E ratio of 15.2 and P/S ratio of 1. The dividend yield of Ingersoll-rand Plc stocks is 1.4%.

Ingersoll-Rand Plc reported diluted earnings per share from continuing operations of $1.14 for the second quarter of 2012. The company reported net earnings of $365.8 million, or EPS of $1.16, for the second quarter of 2012. Second-quarter net earnings included $358.0 million, or EPS of $1.14, from continuing operations, as well as $7.8 million, or EPS of $0.02 from discontinued operations.

Pfizer Inc. ( PFE ) Reached the 52-Week High of $24.515

The prices of Pfizer Inc. ( PFE ) shares have reached $24.515, which is 0.4% off the 52-week high of $24.61. Pfizer Inc is a research-based, global pharmaceutical company that discovers and develops innovative, value-added products that improve the quality of life of people around the world and help them enjoy longer, healthier, and more productive lives. Pfizer Inc. has a market cap of $181.06 billion; its shares were traded at around $24.515 with a P/E ratio of 10.5 and P/S ratio of 2.7. The dividend yield of Pfizer Inc. stocks is 3.6%. Pfizer Inc. had an annual average earnings growth of 0.5% over the past 10 years.

Executive Vice President Laurie J. Olson and Executive Vice President Douglas M. Lankler sold shares of PFE stock.

[url=http://www.gurufocus.com/52weekhigh.php]Check out[/url] the complete list of 52-week highs.

About GuruFocus: GuruFocus.com tracks the stocks picks and portfolio holdings of the world's best investors. This value investing site offers stock screeners and valuation tools. And publishes daily articles tracking the latest moves of the world's best investors. GuruFocus also provides promising stock ideas in 3 monthly newsletters sent to Premium Members .




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing

Referenced Stocks: BDX , BIIB , GE , IR , PFE

GuruFocus

GuruFocus

More from GuruFocus:

Related Videos

Don't Pay Up to Play REITs
Don't Pay Up to Play REITs          

Stocks

Referenced

100%
78%
89%
100%
87%

Most Active by Volume

100,376,898
  • $17.62 ▲ 0.51%
83,231,837
  • $25.62 ▲ 1.91%
75,739,329
  • $111.78 ▼ 0.77%
65,297,937
  • $36.37 ▼ 1.76%
59,053,093
  • $47.66 ▲ 0.29%
53,482,350
  • $2.59 ▼ 0.38%
51,504,284
  • $7.34 ▲ 2.37%
51,434,656
  • $8.14 ▲ 6.96%
As of 12/19/2014, 04:15 PM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com